Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05363046 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Noninterventional Study Evaluating Parkinson's Disease Diary Use

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 31, 2024 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 400 to confirmed 194
    • Site details revised at 34 of 34 sites
    v7
  2. Site details revised at 4 of 34 sitesv6
  3. Enrollment target: 500 to 400
    • Study sites: 15 to 34
    • Study description expanded, about 6 words
    • Eligibility criteria expanded, about 4 words
    v5
  4. Study sites: 1 to 15v4
  5. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Jun 30, 2023 to Oct 2025
    • Study sites: 0 to 1
    • Study completion date: Jun 30, 2024 to Oct 2026
    • Start date changed from estimate of Jun 30, 2022 to Jul 29, 2022
  6. Re-verified, no change to tracked fieldsv2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to evaluate the impact of the frequency of assessments on the variability over time, reliability, and compliance for the Parkinson's disease (PD) diary in patients with PD in whom medications do not provide adequate control of symptoms.
Trial Details
NCT Number NCT05363046
Lead Sponsor BlueRock Therapeutics
Conditions
(from sponsor)		 Parkinson's Disease
Related terms Parkinson Disease
Enrollment 194 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov